KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Non-Current Debt (2018 - 2025)

Twist Bioscience (TWST) has disclosed Non-Current Debt for 5 consecutive years, with $15.0 million as the latest value for Q4 2025.

  • Quarterly Non-Current Debt changed 0.0% to $15.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $15.0 million for FY2025, N/A changed from the prior year.
  • Non-Current Debt for Q4 2025 was $15.0 million at Twist Bioscience, roughly flat from $15.0 million in the prior quarter.
  • The five-year high for Non-Current Debt was $15.0 million in Q4 2024, with the low at $15.0 million in Q4 2024.